Randomized controlled trial of a home-basedwalking program to reducemoderate to severe aromatase inhibitor-associated arthralgia in breast cancer survivors

Oncologist

Volumn 22, Issue 10, 2017, Pages 1238-1248

  Nyrop, Kirsten A ^a,b   Callahan, Leigh F ^a   Cleveland, Rebecca J ^a   Arbeeva, Liubov L ^a   Hackney, Betsy S ^a   Muss, Hyman B ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Aromatase inhibitor; Arthralgia; Breast cancer; Exercise

Indexed keywords

AROMATASE INHIBITOR;

ADULT; ARTHRALGIA; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVOR; DAILY LIFE ACTIVITY; EXERCISE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; WALKING; WALKING DIFFICULTY; BREAST TUMOR; CHEMICALLY INDUCED; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; MIDDLE AGED; MORTALITY; PATHOLOGY; PSYCHOLOGY;

ACTIVITIES OF DAILY LIVING; AROMATASE INHIBITORS; ARTHRALGIA; BREAST NEOPLASMS; CANCER SURVIVORS; FEMALE; HUMANS; MIDDLE AGED; WALKING;

EID: 85034022286     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2017-0174     Document Type: Article

References (28)

1. Burstein HJ, Griggs JJ, Prestrud AA et al. American Society of Clinical Oncology clinical practice guideline update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Oncol Pract 2010;6:243-246.
2. Taylor WC, Muss HB. Recent advances: Adjuvant therapy for older women with breast cancer. Cancer J 2010;16:289-293.
3. Beckwee D, Leysen L, Meuwis K et al. Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: A systematic review and meta-analysis. Support Care Cancer 2017;25:1673-1686.
4. Crew KD, Greenlee H, Capodice J et al. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 2007;25:3877-3883.
5. Dent SF, Gaspo R, Kissner M et al. Aromatase inhibitor therapy: Toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer. Breast Cancer Res Treat 2011;126:295-310.
6. Roberts K, Rickett K, Greer R et al. Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early breast cancer: A systematic review and meta-analysis. Crit Rev Oncol Hematol 2017;111:66-80.
7. Callahan LF, Shreffler JH, AltpeterMet al. Evaluation of group and self-directed formats of the Arthritis Foundation’s Walk with Ease program. Arth Care Res 2011;63:1098-1107.
8. Nyrop KA, Muss HB, Hackney B et al. Feasibility and promise of a 6-week program to encourage physical activity and reduce joint symptoms among elderly breast cancer survivors on aromatase inhibitor therapy. J Geriatr Oncol 2014;5:148-155.
9. Nyrop KA, Callahan LF, Rini C et al. Adaptation of an evidence-based arthritis program for breast cancer survivors on aromatase inhibitor therapy who experience joint pain. Prev Chronic Dis 2015;12:E91.
10. Nyrop KA, Callahan LF, Rini C et al. Aromatase inhibitor associated arthralgia: The importance of oncology provider-patient communication about side effects and potential management through physical activity. Support Care Cancer 2016;24: 2643-2650.
11. Cella D, Riley W, Stone A et al. The Patient- Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol 2010;63:1179-1194.
12. Kushi LH, Doyle C, McCullough M et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin 2012;62:30-67.
13. Arthritis Foundation. Walk with Ease: Your Guide to Walking for Better Health, Improved Fitness and Less Pain (Third Edition). Atlanta, GA: Arthritis Foundation, 2010.
14. Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 1983;16:87-101.
15. Bellamy N, Buchanan WW, Goldsmith CH et al. Validation study of WOMAC: A health status instrument for measuring clinically-important patient relevant outcomes following total hip or knee arthroplasty in osteoarthritis. J Orthoped Rheumatol 1988;1:95-108.
16. Cella DF, Tulsky DS, Gray G et al. The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncol 1993;11:570-579.
17. DeVellis RF, Callahan LF. A brief measure of helplessness in rheumatic disease: The helplessness subscale of the Rheumatology Attitudes Index. J Rheumatol 1993;20:866-869.
18. Brady TJ. Measures of self-efficacy, helplessness, mastery, and control: The Arthritis Helplessness Index (AHI)/Rheumatology Attitudes Index (RAI), Arthritis Self-Efficacy Scale (ASES), Children’s Arthritis Self-Efficacy Scale (CASE), Generalized Self- Efficacy Scale (GSES), Mastery Scale, Multi- Dimensional Health Locus of Control Scale (MHLC), Parent’s Arthritis Self-Efficacy Scale (PASE), Rheumatoid Arthritis Self-Efficacy Scale (RASE), and Self- Efficacy Scale (SES). Arthritis Care Res 2003;49: S147-S164.
19. Resnick B, Zimmerman SI, Orwig D et al. Outcome expectations for exercise scale: Utility and psychometrics. J Gerontol B Psychol Sci Soc Sci 2000;55: S352-S356.
20. Marcus BH, Selby VC, Niaura RS et al. Self-efficacy and the stages of exercise behavior change. Res Q Exerc Sport 1992;63:60-66.
21. Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press, 1977.
22. Ader R, Cohen N, Felten DL. Brain, behavior, and immunity. Brain Behav Immun 1987;1:1-6.
23. Irwin ML, Cartmel B, Gross CP et al. Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. J Clin Oncol 2014 [Epub ahead of print].
24. Arem H, Sorkin M, Cartmel B et al. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: The Hormones and Physical Exercise (HOPE) study. J Cancer Surviv 2016;10:654-662.
25. Cantarero-Villanueva I, Fernandez-Lao C, Caro-Moran E et al. Aquatic exercise in a chest-high pool for hormone therapy-induced arthralgia in breast cancer survivors: A pragmatic controlled trial. Clin Rehab 2013;27:123-132.
26. Fields J, Richardson A, Hopkinson J et al. Nordic walking as an exercise intervention to reduce pain in women with aromatase inhibitor-associated arthralgia: A feasibility study. J Pain Symptom Manage 2016;52:548-559.
27. DeNysschen CA, Burton H, Ademuyiwa F et al. Exercise intervention in breast cancer patients with aromatase inhibitor-associated arthralgia: A pilot study. Eur J Cancer Care 2014;23:493-501.
28. Yang GS, Kim HJ, Griffith KA et al. Interventions for the treatment of aromatase inhibitor-associated arthralgia in breast cancer survivors: A systematic review and meta-analysis. Cancer Nurs 2016;40:E26-E41.